These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2987969)

  • 1. Potentiation of antiherpetic activity of acyclovir by ribonucleotide reductase inhibition.
    Spector T; Averett DR; Nelson DJ; Lambe CU; Morrison RW; St Clair MH; Furman PA
    Proc Natl Acad Sci U S A; 1985 Jun; 82(12):4254-7. PubMed ID: 2987969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2-Acetylpyridine 5-[(dimethylamino)thiocarbonyl]-thiocarbonohydrazone (A1110U), a potent inactivator of ribonucleotide reductases of herpes simplex and varicella-zoster viruses and a potentiator of acyclovir.
    Spector T; Harrington JA; Morrison RW; Lambe CU; Nelson DJ; Averett DR; Biron K; Furman PA
    Proc Natl Acad Sci U S A; 1989 Feb; 86(3):1051-5. PubMed ID: 2536930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivators of herpes simplex virus ribonucleotide reductase: hematological profiles and in vivo potentiation of the antiviral activity of acyclovir.
    Spector T; Lobe DC; Ellis MN; Blumenkopf TA; Szczech GM
    Antimicrob Agents Chemother; 1992 May; 36(5):934-7. PubMed ID: 1324641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ribonucleotide reductase induced by varicella zoster virus. Characterization, and potentiation of acyclovir by its inhibition.
    Spector T; Stonehuerner JG; Biron KK; Averett DR
    Biochem Pharmacol; 1987 Dec; 36(24):4341-6. PubMed ID: 2825724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of ribonucleotide reductase inhibition on pyrimidine deoxynucleotide metabolism in acyclovir-treated cells infected with herpes simplex virus type 1.
    Karlsson A; Harmenberg J
    Antimicrob Agents Chemother; 1988 Jul; 32(7):1100-2. PubMed ID: 2847642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ribonucleotide reductase: an important enzyme in the replication of herpes simplex virus type 1 and a target for antiviral chemotherapy.
    Prichard MN; Shipman C
    Chemotherapy; 1995; 41(5):384-95. PubMed ID: 8521741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antiviral activity of the ribonucleotide reductase inhibitor BILD 1351 SE in combination with acyclovir against HSV type-1 in cell culture.
    Lawetz C; Liuzzi M
    Antiviral Res; 1998 Jul; 39(1):35-46. PubMed ID: 9754948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective inhibition of herpes simplex virus ribonucleoside diphosphate reductase by derivatives of 2-acetylpyridine thiosemicarbazone.
    Turk SR; Shipman C; Drach JC
    Biochem Pharmacol; 1986 May; 35(9):1539-45. PubMed ID: 3011019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Herpes simplex virus ribonucleotide reductase mutants are hypersensitive to acyclovir.
    Coen DM; Goldstein DJ; Weller SK
    Antimicrob Agents Chemother; 1989 Aug; 33(8):1395-9. PubMed ID: 2552912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-Acetylpyridine thiocarbonohydrazones. Potent inactivators of herpes simplex virus ribonucleotide reductase.
    Blumenkopf TA; Harrington JA; Koble CS; Bankston DD; Morrison RW; Bigham EC; Styles VL; Spector T
    J Med Chem; 1992 Jun; 35(12):2306-14. PubMed ID: 1319497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic topical therapy by acyclovir and A1110U for herpes simplex virus induced zosteriform rash in mice.
    Lobe DC; Spector T; Ellis MN
    Antiviral Res; 1991 Feb; 15(2):87-100. PubMed ID: 1650166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral ribonucleotide reductase attenuates the anti-herpes activity of acyclovir in contrast to amenamevir.
    Shiraki K; Tan L; Daikoku T; Takemoto M; Sato N; Yoshida Y
    Antiviral Res; 2020 Aug; 180():104829. PubMed ID: 32569704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of a herpes simplex virus ribonucleotide reductase null mutant to deoxyribonucleosides and antiviral nucleoside analogs.
    Yamada Y; Yamamoto N; Daikoku T; Nishiyama Y
    Microbiol Immunol; 1991; 35(8):681-6. PubMed ID: 1661366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo evaluation of a novel antiherpetic flavonoid, 4'-phenylflavone, and its synergistic actions with acyclovir.
    Hayashi K; Iinuma M; Sasaki K; Hayashi T
    Arch Virol; 2012 Aug; 157(8):1489-98. PubMed ID: 22580497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic effects of acyclovir and 3, 19-isopropylideneandrographolide on herpes simplex virus wild types and drug-resistant strains.
    Priengprom T; Ekalaksananan T; Kongyingyoes B; Suebsasana S; Aromdee C; Pientong C
    BMC Complement Altern Med; 2015 Mar; 15():56. PubMed ID: 25879785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel thiosemicarbazones derived from formyl- and acyldiazines: synthesis, effects on cell proliferation, and synergism with antiviral agents.
    Easmon J; Heinisch G; Holzer W; Rosenwirth B
    J Med Chem; 1992 Aug; 35(17):3288-96. PubMed ID: 1354751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herpes and human ribonucleotide reductases. Inhibition by 2-acetylpyridine 5-[(2-chloroanilino)-thiocarbonyl]-thiocarbonohydrazone (348U87).
    Spector T; Harrington JA; Porter DJ
    Biochem Pharmacol; 1991 Jun; 42(1):91-6. PubMed ID: 1648925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of cell culture conditions on the inhibition of herpes simplex virus type 1 replication by acyclovir.
    Harmenberg J; Wahren B
    Intervirology; 1982; 17(4):215-21. PubMed ID: 6290415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationships among alpha-(N)-heterocyclic acyl thiosemicarbazones and related compounds as inhibitors of herpes simplex virus type 1-specified ribonucleoside diphosphate reductase.
    Turk SR; Shipman C; Drach JC
    J Gen Virol; 1986 Aug; 67 ( Pt 8)():1625-32. PubMed ID: 3016157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acyclovir: mechanism of antiviral action and potentiation by ribonucleotide reductase inhibitors.
    Reardon JE; Spector T
    Adv Pharmacol; 1991; 22():1-27. PubMed ID: 1958500
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.